Target intelligence / Profile preview

Inactive ubiquitin thioesterase OTULINL (OTULINL)

Target
OTULINL
Molecular classification
Other (pseudo-deubiquitinase, OTU subfamily)
01

Overview

Inactive ubiquitin thioesterase OTULINL (OTULINL) is a protein coding gene in humans, located on the cytoplasmic side of the endoplasmic reticulum membrane and nuclear envelope[2]. It is structurally similar to the deubiquitinase OTULIN (FAM105B), but lacks the conserved catalytic cysteine in the active site, being substituted by an aspartate residue, rendering it catalytically inactive[6][3][7][8]. The molecular structure of OTULINL (FAM105A) reveals deficiencies in both its active site and its substrate binding site, which confirms its classification as a pseudo-deubiquitinase[3][7][8]. Functionally, OTULINL appears to participate in protein-protein interactions rather than ubiquitin cleavage, but the precise biological roles remain unclear. Unlike OTULIN, which has critical roles in immune signaling, cell death, and NF-kB regulation, OTULINL has no established functional role in canonical ubiquitin-dependent processes or disease mechanisms[1][2]. Direct drug interactions, mechanism of action, biomarker utility, or safety issues have not been reported for OTULINL[2][3][6].

Other names
OTULINLFAM105ANET20FLJ11127inactive ubiquitin thioesterase OTULINLfamily with sequence similarity 105 member Aprotein FAM105A
02

Biological functions

Protein-protein interactions at the endoplasmic reticulum membrane and nuclear envelope
03

Disease associations

Other: Gene associations have been reported with rare syndromes such as autoinflammation, panniculitis, and dermatosis syndrome (autosomal recessive), and Achromatopsia 3, but direct mechanistic roles are unclear

Beyond the preview

Go deeper on Inactive ubiquitin thioesterase OTULINL (OTULINL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inactive ubiquitin thioesterase OTULINL (OTULINL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call